David L. Katz, MD, MPH, FACPM, FACP, FACLM, is the Founding Director (1998) of Yale University’s Yale-Griffin Prevention Research Center, and former President of the American College of Lifestyle Medicine. He has published roughly 200 scientific articles and textbook chapters, and 15 books to date, including multiple editions of leading textbooks in both preventive medicine, and nutrition. He has made important contributions in the areas of lifestyle interventions for health promotion; nutrient profiling; behavior modification; holistic care; and evidence-based medicine. David earned his BA degree from Dartmouth College (1984); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He completed sequential residency training in Internal Medicine, and Preventive Medicine/Public Health. He is a two-time diplomate of the American Board of Internal Medicine, and a board-certified specialist in Preventive Medicine/Public Health. He has received two Honorary Doctorates.
As the dairy debate continues, it is crucial to critically examine research findings and avoid falling for sensationalized headlines.
Berberine (a botanical extract taken as a supplement) is not “Nature’s Ozempic,” nor is it useless; the truth, as so often, is in between. Ozempic, for that matter, is not a panacea, has known liabilities now, while the full scope of costs attached to its apparent benefits will likely only be known in the fullness of time. Obesity is a dysfunction of the body politic, which turns a blind eye as entities profit both from its propagation and its treatment, far more than it is a dysfunction of our individual bodies. Thus, if obesity is any kind of “disease,” it is a social disease, a malady of cultural apathy, and worse.